INTERFERON

Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies
Alessandra Aiello, Andrea Coppola, Serena Ruggieri, Chiara Farroni, Anna Maria Gerarda Altera, Andrea Salmi, Valentina Vanini, Gilda Cuzzi, Linda Petrone, Silvia Meschi, Daniele Lapa, Aurora Bettini, Shalom Haggiag, Luca Prosperini, Simonetta Galgani, Maria Esmeralda Quartuccio, Nazario Bevilacqua, Anna Rosa Garbuglia, Chiara Agrati, Vincenzo Puro, Carla Tortorella, Claudio Gasperini, Emanuele Nicastri, Delia Goletti

Journal of Neurology, Neurosurgery & Psychiatry Apr 2023, 94 (4) 290-299; DOI: 10.1136/jnnp-2022-330175
The unintended consequences of NICE
Gavin Giovannoni

Journal of Neurology, Neurosurgery & Psychiatry Mar 2019, 90 (3) 247-248; DOI: 10.1136/jnnp-2018-318866
TRAIL and TRAIL receptors splice variants during long-term interferon β treatment of patients with multiple sclerosis: evaluation as biomarkers for therapeutic response
Carlos López-Gómez, Begoña Oliver-Martos, María-Jesús Pinto-Medel, Margarita Suardiaz, Virginia Reyes-Garrido, Patricia Urbaneja, Óscar Fernández, Laura Leyva

Journal of Neurology, Neurosurgery & Psychiatry Feb 2016, 87 (2) 130-137; DOI: 10.1136/jnnp-2014-309932
Factors influencing long-term outcomes in relapsing–remitting multiple sclerosis: PRISMS-15
Ludwig Kappos, Jens Kuhle, Juha Multanen, Marcelo Kremenchutzky, Elisabetta Verdun di Cantogno, Peter Cornelisse, Lorenz Lehr, Florence Casset-Semanaz, Delphine Issard, Bernard M J Uitdehaag

Journal of Neurology, Neurosurgery & Psychiatry Nov 2015, 86 (11) 1202-1207; DOI: 10.1136/jnnp-2014-310024
Pregnancy outcomes in patients exposed to interferon beta-1b
Rebecca S Romero, Claudia Lünzmann, Jöerg-Peter Bugge

Journal of Neurology, Neurosurgery & Psychiatry May 2015, 86 (5) 587-589; DOI: 10.1136/jnnp-2014-308113
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT
G Edan, L Kappos, X Montalbán, C H Polman, M S Freedman, H-P Hartung, D Miller, F Barkhof, J Herrmann, V Lanius, B Stemper, C Pohl, R Sandbrink, D Pleimes

Journal of Neurology, Neurosurgery & Psychiatry Nov 2014, 85 (11) 1183-1189; DOI: 10.1136/jnnp-2013-306222
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes
Richard W Browne, Bianca Weinstock-Guttman, Dana Horakova, Robert Zivadinov, Mary Lou Bodziak, Miriam Tamaño-Blanco, Darlene Badgett, Michaela Tyblova, Manuela Vaneckova, Zdenek Seidl, Jan Krasensky, Niels Bergsland, Deepa P Ramasamy, Jesper Hagemeier, Eva Havrdova, Murali Ramanathan

Journal of Neurology, Neurosurgery & Psychiatry Aug 2014, 85 (8) 859-864; DOI: 10.1136/jnnp-2013-307106
Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes
Nicola De Stefano, Giancarlo Comi, Ludwig Kappos, Mark S Freedman, Chris H Polman, Bernard M J Uitdehaag, Brian Hennessy, Florence Casset-Semanaz, Lorenz Lehr, Bettina Stubinski, Dominic L Jack, Frederik Barkhof

Journal of Neurology, Neurosurgery & Psychiatry Jun 2014, 85 (6) 647-653; DOI: 10.1136/jnnp-2013-306289
A nexus between lipids and multiple sclerosis?
Marino Zorzon

Journal of Neurology, Neurosurgery & Psychiatry Nov 2013, 84 (11) 1181; DOI: 10.1136/jnnp-2013-305240

Log in using your username and password

Main menu

Log in using your username and password

You are here

INTERFERON